JCR Pharmaceuticals Co., Ltd. (TYO:4552)

JCR Pharmaceuticals Revenue

JCR Pharmaceuticals had revenue of 12.79B JPY in the quarter ending September 30, 2025, with 50.29% growth. This brings the company's revenue in the last twelve months to 37.78B, up 7.15% year-over-year. In the fiscal year ending March 31, 2025, JCR Pharmaceuticals had annual revenue of 33.07B, down -22.86%.

• Revenue (ttm): 37.78B
• Revenue Growth: +7.15%
• P/S Ratio: 2.19
• Revenue / Employee: 38.27M
• Employees: 987
• Market Cap: 82.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	33.07B	-9.80B	-22.86%
Mar 31, 2024	42.87B	8.53B	24.83%
Mar 31, 2023	34.34B	-16.74B	-32.77%
Mar 31, 2022	51.08B	21.00B	69.79%
Mar 31, 2021	30.09B	5.30B	21.40%